Craft

Syngene International

Stock Price

₹868.8

2024-08-30

Market Capitalization

₹348.2 B

2024-08-30

Revenue

₹33.7 B

FY, 2024

Syngene International Summary

Company Summary

Overview
Syngene International is integrated research, development, and manufacturing company providing scientific services. It conducts early-stage research, pre-clinical and clinical trials, drug substance and drug product development, biologics manufacturing, and other services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical industries.
Type
Public
Status
Active
Founded
1993
HQ
Bangalore, IN | view all locations
Website
https://syngeneintl.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

Operating MetricsView all

Engineers And Scientists

4.2K
5.1%

FY, 2020

Active Clients

360
8.8%

FY, 2020

Patents Issued

400

FY, 2020

LocationsView all

3 locations detected

  • Bangalore, KA HQ

    India

    Bommasandra Industrial Area – Phase-IV, Jigani Link Road

  • Bangalore, KA

    India

    No.39 A, Near Semicon Park, Electronic city, Phase II Hosur Road

  • Bengaluru, KA

    India

    No.39 A, Hosur Rd, near Semicon Park, Electronic City Phase II, Electronic City

Syngene International Financials

Summary Financials

Revenue (Q1, 2025)
₹7.9B
Gross profit (Q1, 2025)
₹5.7B
Net income (Q1, 2025)
₹757.0M
Cash (FY, 2024)
₹5.6B
EBIT (Q1, 2025)
₹1.2B
Enterprise value
$348.1B

Footer menu